Biodesix (BDSX) Gross Margin (2019 - 2026)

Biodesix (BDSX) has 8 years of Gross Margin data on file, last reported at 83.55% in Q1 2026.

• Quarterly Gross Margin rose 417.0% year-over-year to 83.55% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 82.08% (up 370.0% YoY) and the FY2025 annual result came in at 81.11%, up 294.0% from the prior year.
• Gross Margin improved to 83.55% in Q1 2026, from 83.03% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 83.55% in Q1 2026 to a low of 50.6% in Q1 2022.
• A 5-year average of 73.97% and a median of 77.0% in 2023 frame the typical range for Gross Margin.
• The widest YoY moves for Gross Margin: up 2327 bps in 2022, down 10 bps in 2022.
• Tracing BDSX's Gross Margin over 5 years: stood at 65.59% in 2022, then rose by 17 bps to 77.0% in 2023, then increased by 2 bps to 78.75% in 2024, then increased by 5 bps to 83.03% in 2025, then climbed by 1 bps to 83.55% in 2026.
• The last three Gross Margin figures came in at 83.55% (Q1 2026), 83.03% (Q4 2025), and 81.14% (Q3 2025), per Business Quant data.